[A new case of rare erythrocytosis due to EGLN1 mutation with review of the literature]

Rev Med Interne. 2020 Mar;41(3):196-199. doi: 10.1016/j.revmed.2019.12.019. Epub 2020 Jan 21.
[Article in French]

Abstract

Introduction: The origin of polycythemia is often simple to detect. Sometimes it is necessary to look for hereditary forms, the decisive parameters being the dosage of erythropoietin and the measurement of the oxygen dissociation curve (P50). These rare diseases are related to high oxygen-affinity haemoglobins, abnormalities of the erythropoietin receptor or dysfunction of the HIF (hypoxia-inducible factor) pathway.

Case report: We report the case of a 56-year-old patient with unexplained polycythemia associated with normal serum erythropoietin and normal P50, in whom the never previously described mutation c.400C>T(p.Gln134*) on exon 1 in the EGLN1 gene (encoding PHD2) was found.

Conclusion: In the face of an unexplained polycythemia a good cooperation between clinicians and biologists is necessary to be able to characterize rare hereditary pathologies.

Keywords: C.400C>T (p.Gln134*); EGLN1 mutation; Hereditary erythrocytosis; Hypoxia pathway; Hypoxie; Mutation EGLN1; PHD2; Polyglobulie héréditaire.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Erythropoietin / blood
  • Family
  • Humans
  • Hypoxia / blood
  • Hypoxia / genetics
  • Hypoxia-Inducible Factor-Proline Dioxygenases / genetics*
  • Male
  • Middle Aged
  • Mutation
  • Polycythemia / blood
  • Polycythemia / diagnosis*
  • Polycythemia / genetics*

Substances

  • EPO protein, human
  • Erythropoietin
  • EGLN1 protein, human
  • Hypoxia-Inducible Factor-Proline Dioxygenases